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HYPERTROPHY 
Epicardial Coronary Arteries Are Not Adequately Sized in 
Hypertensive Patients 
ALAIN  N ITENBERG,  MD,  ISABELLE  ANTONY,  MD 
Paris, France 
Objectives. This study sought to compare coronary artery 
dimensions in hypertensive patients and normal subjects. 
Background. Myocardial oxygen demand at rest and corre- 
sponding coronary blood flow are the main determinants of large 
coronary artery dimensions in humans. Coronary diameters are 
increased in aortic valve disease. 
Methods. Left main, proximal and distal left anterior descend- 
ing and proximal circumflex coronary artery diameters were 
measured by quantitative angiography in 10 control subjects 
(group 1) and 26 untreated hypertensive patients, 12 without 
(group 2a) and 14 with (group 2b) left ventricular hypertrophy. 
All patients had normal cholesterol levels and angiographically 
normal coronary arteries. Measurements were made at baseline 
and after 2 mg of intracoronary isosorbide dinitrate to obtain 
maximal dimensions of vessels. Coronary flow velocity was mea- 
sured in the distal left anterior descending coronary artery by 
Doppler ultrasound. 
Results. Despite a higher ate-pressure product in hypertensive 
patients, all segment diameters were slightly but not significantly 
higher at baseline in group 2b than in groups 1 and 2a. Diameters 
were similar in the three groups after isosorbide dinitrate. Con- 
versely, coronary flow velocity was significantly higher in hyper- 
tensive patients than in group 1 either at baseline (10.4 _+ 2.2 
[mean + SD] cnfs [group 2a] and 12.8 +- 2.4 cm/s [group 2b] vs. 
6.5 -+ 2.0 cm/s [group 1], all p < 0.001) or after isosorbide 
dinitrate (6.8 -+ 2.8 cm/s [group 2a] and 7.8 -+ 2.1 cm/s [group 2b] 
vs. 3.7 + 0.8 cm/s [group 1], p < 0.01 and p < 0.001, respectively). 
Conclusions. Despite an elevated myocardial oxygen demand, 
maximal dimensions of large coronary arteries are not increased 
in hypertensive patients, resulting in an elevated coronary flow 
velocity that may increase longitudinal shear stress at the endo- 
thelial surface. This elevated flow velocity might be an important 
determinant in the pathogenesis of atherosclerosis in hyperten- 
sive patients. 
(J Am Coil Cardiol 1996;27:115-23) 
Hypertension is an important coronary risk factor (1,2). In 
arterial hypertension, myocardial oxygen demand is elevated, 
and because myocardial oxygen demand and corresponding 
coronary blood flow are the main determinants of coronary 
artery dimensions (3-6), coronary artery dimensions hould 
increase to maintain coronary flow velocity and endothelial 
shear stress constant (7,8). It has been suggested that large 
coronary vessels are prone to develop atherosclerosis because 
of exposure to high pulsatile pressure and blood flow velocity 
that increase endothelial shear stress (9,10). This stress can 
elicit endothelial dysfunction or denudation that result in 
increased endothelial permeability and lipoprotein deposition 
(11,12), leading to the formation of atherosclerotic plaques 
(13,14). 
The aim of the present study was thus to evaluate basal and 
maximal coronary artery dimensions after intracoronary 
isosorbide dinitrate in patients with arterial hypertension, 
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angiographically normal coronary arteries and no other risk 
factors. 
Methods  
Patient selection. Twenty-six patients with hypertension 
and 10 control normotensive subjects (group 1) undergoing 
diagnostic oronary angiography for evaluation of chest pain 
were studied (10 of 26 hypertensive patients and 9 of 10 control 
subjects were previously evaluated with regard to the effect of 
a cold-pressor test on coronary vasomotion [15]). Control 
subjects had a supine systolic blood pressure <140 mm Hg and 
a diastolic blood pressure <90 mm Hg. All hypertensive 
patients had a well established history of elevated blood 
pressure >140/90 mm Hg, with at least four sets of readings 
taken at 1-week intervals. In 17 patients, hypertension was 
recently diagnosed (<3 months) and had never been treated. 
In nine other patients, hypertension was treated < 1 year, and 
antihypertensive therapy was discontinued at least 3 weeks 
before cardiac catheterization because of inefficacy of the 
treatment. Patients with a history of smoking >five cigarettes/ 
day or diabetes mellitus, and patients with hypercholester- 
olemia (total cholesterol serum level >5.70 mmol/liter 
[220 mg/dl] or low density lipoprotein cholesterol level 
©1996 by the American College of Cardiology 0735-1097/96/$15.00 
0735-1097(95 )00417-3 
116 NITENBERG AND ANTONY JACC Vol. 27, No. 1 
CORONARY ARTERIES IN HYPERTENSION January 1996:115-23 
>3.70 mmol/liter [143 mg/dl]) were excluded. No patient had a 
family history of coronary artery disease. 
Left ventricular systolic function assessed by two-dimensional 
and M-mode echocardiography was normal in all patients. Left 
ventricular dimensions and septal and posterior wall thick- 
nesses were measured at end-diastole, according to the Amer- 
ican Society of Echocardiography guidelines (16). The left 
ventricular mass index was calculated at end-diastole by the 
Penn convention (17). Hypertensive patients were classified 
into two groups: group 2a = no left ventricular hypertrophy 
(left ventricular mass -<110 g/m2; group 2b = left ventricular 
hypertrophy present (left ventricular mass ->125 g/m2). 
After diagnostic oronary arteriography, patients were in- 
cluded by consensus of two experienced investigators on 
immediate r view of the angiograms, if coronary arteries were 
without lumen irregularities. The protocol was approved by the 
Institutional Review Committee of the University of Kremlin- 
Bic~tre. All patients gave written informed consent before 
cardiac catheterization. 
Catheterization protocol. Patients were studied in the fast- 
ing state. Nitrate therapy, when given, was withheld for at least 
24 b. No prernedication was administered; 1% lidocaine was 
used for local anesthesia, nd 5,000 U of heparin was admin- 
istered intravenously. Diagnostic left heart catheterization a d 
coronary arteriography were performed by the percutaneous 
femoral approach using 6F catheters. After documentation f 
normal coronary arteries, at least 15 rain was allowed to elapse 
before subsequent measurements. After additional dministra- 
tion of 5,000 U of heparin, an 8F guiding catheter was 
positioned in the left main coronary artery. A 3F 20-MHz 
coronary Doppler catheter (Monorail Doppler 3, Schneider 
Europe AG, Zurich, Switzerland) connected to a single- 
channel 20-MHz pulsed Doppler velocimeter (model MDV-20 
Single-Channel Velocimeter, Millar Instruments, Inc.) was 
placed in the left anterior descending coronary artery. The 
proximal umen of the Doppler catheter was placed in the 
midportion of the left anterior descending coronary artery 
using a contrast medium injection. Catheter position was 
adjusted to obtain an optimal audio signal and phasic tracing of 
coronary blood flow velocity. Heart rate, aortic pressure 
(through the guiding catheter), mean and phasic blood flow 
velocity (kHz shift) and electrocardiograms (ECGs) were 
continuously monitored throughout the protocol. 
Left coronary angiography was performed using an injec- 
tion of 8 ml of low osmolarity contrast medium (meglumine 
ioxaglate). Measurements of left main, proximal circumflex 
and proximal and distal left anterior descending coronary 
artery diameters near the tip of the Doppler catheter (Fig. 1) 
were made before (baseline) and 4 min after intracoronary 
infusion of 2 mg of isosorbide dinitrate to obtain maximal 
epicardial coronary vasodilation. Intracoronary blood flow 
velocity was measured in the distal left anterior descending 
coronary artery just before each coronary angiogram to avoid 
the hyperemic effects of the contrast medium. 
Quantitative coronary arteriography. Coronary arterio- 
grams were obtained by ECG-triggered digital subtraction ata 
~roximal 
(LAD1) 
and 
Distal 
(LAD2) 
,ft anterior 
escending 
Figure 1. Schematic representation f the right anterior oblique 
projection of the left coronary artery showing the locations of the four 
segments where diameter measurements were made. 
rate of 6 frames/s on a 512-pixel matrix (General Electric CGR 
DG 300, General Electric, Issy-les-Moulineaux, France). The 
angiographic system was set up in the right anterior oblique 
position with adequate cranial or caudal angulation allowing 
optimal views of the left main, circumflex and proximal and 
distal left anterior descending coronary artery segments on 
end-diastole frames without overlap by side branches. Rela- 
tions among focal spot, patient and height of image tube were 
kept constant throughout the procedure. 
The method for analysis of angiograms has been described 
elsewhere (15). Briefly, reliability and accuracy of the method 
have previously been established (15) for seven empty cathe- 
ters ranging from 3F to 9F and nine calibrated contrast- 
medium-filled catheters ranging from 1 to 5 mm in internal 
diameter. Diameters (in pixels) were measured perpendicu- 
larly to the centerline on nonsubtracted images. About three 
diameters were determined per millimeter in length, and an 
averaged value representing the mean reference diameter was 
provided for the whole segment. All geometric diameter 
measurements were corrected by a magnification factor taking 
into account the spread function blurring and image intensifier 
pincushion distortion. The accuracy of the technique was 3.6 _+ 
0.5% (mean + SD) and the precision 2.4 _+ 0.9%. The maximal 
error between actual and calculated iameters was _+5.7% 
(R 2 = 0.994). A segment of the guiding catheter positioned in 
the left main coronary artery and filled with saline was placed 
close to the center of the image and was used as a scaling 
device for calibration before the beginning of the procedure. 
Six- to 10-ram long left main (when possible), circumflex and 
proximal and distal left anterior descending coronary artery 
segments were analyzed as previously described, and the mean 
diameter was calculated for each coronary segment from a 
series of diameter measurements (18to 30). Each segment was 
defined with two anatomic references to measure the same 
segment reproducibly after each injection. All diameter mea- 
surements were corrected by a magnification factor taking into 
account he distance of the segment from the center of the 
image. 
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Table 1. Clinical Characteristics of 36 Study Patients 
Hypertensive Patients 
Control Subjects: 
Group 1 Group 2a Group 2b p Value 
(n = 10) (n = 12) (n = 14) (group 2a vs. group 2b) 
Male/female (no.) 9/1 8/4 7/7* NS 
Age (yr) 49.3 -- 8.7 50.2 _+ 8.9 53.5 _~ 9.7 NS 
Range 38- 63 33- 68 33- 63 
Body surface area (m 2) 1.85 _+ 0.13 1.91 _+ 0.18 1.88 + 0.17 NS 
LVEDD (mm) 49.1 _+ 1.8 47.6 +_ 4.1 48.3 _+ 4.0 NS 
FS (%) 39.5 _+ 4.5 39.5 _+ 4.5 41.5 _+ 4.3 NS 
SWTh (ram) 9.3 _+ 0.8 11.2 _+ 2.1t 15.1 _+ 1.5~ < 0.001 
PWTh (ram) 8.7 -+ 0.7 9.5 +- 1.4 13.1 _+ 1.4~ < 0.001 
LVM (g) 150 -+ 23 172 _+ 24* 279 _+ 23:~ < 0.001 
LVMI (g/m 2) 81 _+ 11 90 + 13 149 +_ 18:~ < 0.001 
*p < 0.05, tp < 0.01, ~p < 0.001 versus control subjects. Unless otherwise indicated, data presented are mean value 
+_ SD. FS = fractional shortening; Group 2a = hypertensive patients without left ventricular hypertrophy; Group 2b = 
hypertensive patients with left ventricular hypertrophy; LVEDD = left ventricular end-diastolic diameter; LVM = left 
ventricular mass; LVMI = indexed left ventricular mass; PWTh = posterior wall thickness; SWTh - septal wall thickness. 
Estimates of coronary blood flow. Blood flow (F) was 
calculated in the distal left anterior descending coronary artery 
from measurements of mean coronary flow velocity (v) and 
cross-sectional rea (CSA): F = v x CSA. Cross-sectional area 
was calculated from measurements of the distal left anterior 
descending coronary artery diameter (d) assuming a circular 
model: CSA = 7rd2/4. 
Statistical analysis. Results are expressed as mean value + 
SD. Differences among the three groups of patients for clinical 
and biologic characteristics and baseline hemodynamic and 
echocardiographic variables were compared by the nonpara- 
metric Mann-Whitney test. Statistical comparisons among the 
three groups for hemodynamic variables, coronary vessel di- 
ameters and coronary velocity and flow in basal state and 
post-isosorbide dinitrate conditions were carried out by one- 
way analysis of variance followed by the Fisher protected least 
significant difference (PLSD) test. The paired Student t test 
was used for intragroup analysis. Relations between left ven- 
tricular mass and summed cross-sectional area of the proximal 
left anterior descending and circumflex coronary arteries were 
determined by linear regression analysis using the least- 
squares method. Statistical significance was assumed if the null 
hypothesis could be rejected at the 0.05 probability level. 
Resu l t s  
Characteristics of patients. There were more women in 
group 2b than in group 1 (Table 1). Age and body surface area 
of patients were similar in the three groups. Left ventricular 
end-diastolic diameter and fractional shortening were compa- 
rable in the three groups. Left ventricular mass index was 
similar in groups 1 and 2a and was significantly higher in group 
2b than in the other two groups. 
Hemodynamic variables (Table 2) show that heart rate was 
similar in all groups and that all values of aortic pressure were 
significantly elevated in hypertensive patients. Plasma lipid 
concentrations were comparable in the three groups (Table 2). 
Left-dominant coronary circulation was found in one group 
1, one group 2a and three group 2b patients. There was no 
statistical difference among the three groups. 
Coronary artery diameters. Measurement of circumflex 
and proximal and distal left anterior descending coronary 
Table 2. Baseline Hemodynamic Variables and Plasma Lipid Concentrations (mean +- SD) 
Hypertensive Patients 
Control Subjects: 
Group 1 Group 2a Group 2b p Value 
(n - 10) (n - 12) (n - 14) (group 2a vs. group 2b) 
Heart rate (beats/min) 73 _+ 
Aortic systolic pressure (ram Hg) 126 _+ 
Aortic diastolic pressure (mm Hg) 78 - 
Mean aortic pressure (mm Hg) 97 -+ 
Total cholesterol (mmol/liter) 5.05 _+ 
Triglycerides (mmol/liter) 1.37 _+ 
HDL cholesterol (mmol,qiter) 1.60 _+ 
LDL cholesterol (mmol/liter) 3.17 +_ 
10 74 -+ 10 77 -+ 9 NS 
10 173 + 10' 181 +_ 15" NS 
5 105 + 11' 103 + 8* NS 
3 134 +- 11' 133 -+ 10' NS 
0.68 5.03 -- 0.45 5.13 -+ 0.35 NS 
0.21 1.24 -+ 0.51 1.45 -+ 0.33 NS 
0.34 1.73 +- 0.28 1.71 +- 0.46 NS 
0.47 3.03 -+ 0.40 3.22 +- [I.41 NS 
*p < 0.001 versus control subjects. HDL - high density lipoprotein; LDL = low density lipoprotein; other 
abbreviations as in Table 1. 
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Figure 2. Segment diameters in basal state and after intracoronary 
isosorbide dinitrate and segment diameter changes in the control 
subjects (group 1) and in the two groups of hypertensive patients 
(without [group 2a] and with left ventricular hypertrophy [group 2b]). 
Intracoronary isosorbide dinitrate induced significant dilation in all 
segments (all p < 0.001). Comparisons between groups of patients for 
each segment did not show any significant differences, except for the 
circumflex coronary artery at baseline, between the two groups of 
hypertensive patients. CX = proximal left circumflex coronary artery; 
LAD1 = proximal left anterior descending coronary artery; LAD2 = 
distal left anterior descending coronary artery; LM = left main 
coronary artery. Numbers in parentheses = number of segments 
analyzed in each patient group. *p < 0.05, **p < 0.01 versus control 
subjects. 
artery diameters was possible in all patients. In three group 1, 
~< three group 2a and five group 2b patients, the left main artery 
was not measured either because the segment was too short or 
-~ edge detection was inadequate. 
In group 1 basal segment diameter values were not different 
from those obtained by Dodge et al. (18) by quantitative 
angiography or by Manning et al. (19) by magnetic resonance 
imaging. Diameters in group 2b showed a trend to be larger 
-~ than those in the other groups. Conversely, in group 2a there 
-~ was a trend for smaller diameters than in group 1 (Table 3). 
~, However, all differences were not statistically significant, ex- 
,, cept for circumflex artery diameters, which were significantly 
larger in group 2b than in group 2a (Fig. 2). Comparison of the 
37 group 1 segments with the 51 group 2b segments howed 
JACC Vol. 27, No. 1 NITENBERG AND ANTONY 119 
January 1996:115-23 CORONARY ARTERIES IN HYPERTENSION 
average diameters of, respectively, 3.28 _+ 0.91 and 3.52 _+ 
0.92 mm (t = 1.224, p = 0.224, not significant). In addition, the 
average segment diameter in groups 2a and 2b (26 hyperten- 
sive patients, 96 segments, 3.38 _ 0.91 mm) was comparable to
that in group 1 (t = 0.598, p = 0.551, not significant). Last, 
comparison of patients with (group 2b) and without left 
ventricular hypertrophy (groups 1 and 2a) showed a trend to 
larger diameters in the former group but without statistical 
significance (Fig. 2). 
Intracoronary isosorbide din#rate induced significant dilation 
of all segments (all p < 0.001) (Fig. 2). Segment diameters 
were comparable in groups 1 and 2b, but there was a trend 
toward smaller diameters in group 2a than in the other two 
groups (Table 3). Comparison of the 37 group 1 segments and 
the 51 group 2b segments showed that the average diameters 
were, respectively, 4.13 +__ 0.94 and 4.16 _+ 0.99 mm (t = 0.154, 
p = 0.878, not significant). In addition, average segment 
diameters in groups 2a and 2b (26 hypertensive patients, 96 
segments, 4.04 + 0.96 ram) were comparable tothose of group 
1 (t = 0.479, p = 0.639, not significant). Comparisons between 
patients without left ventricular hypertrophy (groups I and 2a) 
and group 2b, and between groups 2a and 2b and group 1, did 
not show any statistical difference (Fig. 2). Percent diameter 
changes (Fig. 2) were lower in group 2a than in group 1 for the 
left main and proximal left anterior descending arteries and in 
group 2b for the left main, proximal left anterior descending 
and circumflex arteries. 
The summed cross-sectional rea for the circumflex and 
proximal eft anterior descending coronary artery segments 
(Fig. 3) showed that at baseline the area was moderately higher 
in group 2b than in group 2a, and there was a trend to higher 
values in group 2b than in group 1. After isosorbide dinitrate, 
values were comparable in the three groups, although there 
was a trend to lower values in group 2a than in groups I and 2b, 
with similar values in the latter two groups. When the cross- 
sectional area was indexed to left ventricular mass, at baseline 
there was a trend to lower values in group 2a than in group 1 
as well as in group 2b than in group 2a. However, the indexed 
area was significantly lower in group 2b than in group 1. After 
isosorbide dinitrate, areas were significantly lower in the two 
groups of hypertensive patients than in group 1. Moreover, the 
area was lower in group 2b than in group 2a. Linear regression 
analysis of summed cross-sectional area of the circumflex and 
proximal eft anterior descending coronary artery versus left 
ventricular mass showed a weak positive correlation at base- 
line, but this correlation was not observed after isosorbide 
dinitrate (Fig. 4). 
Coronary blood flow velocity and coronary blood flow. 
Flow velocity measured at baseline in the distal left anterior 
descending coronary artery (Fig. 5) was significantly higher in 
groups 2a and 2b than in group 1 (10.4 __ 2.2, 12.8 + 2.4 vs. 
6.5 - 2.0 cm/s, respectively), and velocity was higher in group 
2b than in group 2a. After isosorbide dinitratc, flow velocity 
decreased significantly in all groups but remained significantly 
higher in groups 2a and 2b (6.8 _+ 2.8, 7.8 _+ 2.1 vs. 3.7 -=_ 
0.8 cm/s, respectively). 
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Figure 3. Summed cross-sectional area of the proximal left anterior 
descending coronary artery (LADI) and proximal circumflex coronary 
artery (CX) before (Baseline) and after intracoronary isosorbide 
dinitrate (ISDN) in control subjects and in the two groups of hyper- 
tensive patients. ***p < 0.001 versus baseline. The two graphs at the 
bottom of the figure represent the results from the male patients. 
Numbers in parentheses = number of segments analyzed in each 
patient group. Other abbreviations as in Figure 2. 
At baseline, calculated coronary flow and rate-pressure 
product were significantly higher in groups 2a and 2b than in 
group 1 (Table 4), and flow was higher in group 2b than in 
group 2a. Intracoronary isosorbide dinitrate produced a reduc- 
tion in rate-pressure product despite the increase in heart rate 
in the three groups because of the reduction in aortic pressure. 
This latter effect may explain why coronary blood flow was not 
increased after isosorbide dinitrate. Indeed, coronary flow was 
not significantly altered in group 1 or group 2a, and it was 
reduced in group 2b. Flow remained significantly higher than 
in group 1 only in group 2b, and despite ahigher value of flow 
in group 2a, the difference did not reach the threshold of 
significance. Consequently, the ratio of flow velocity to distal 
left anterior descending coronary artery diameter was reduced 
by isosorbide dinitrate in the three groups of patients, but the 
ratios were significantly higher in groups 2a and 2b than in 
group 1 both at baseline and after isosorbide dinitrate (Fig. 5). 
In addition, the ratio was higher in group 2b than in group 2a 
at baseline but not after isosorbide dinitrate. 
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Figure 4. Linear egression analysis of summed cross-sectional area of 
the proximal left anterior descending (LAD1) and circumflex (CX) 
coronary arteries versus left ventricular mass at baseline and after 
intracoronary isosorbide dinitrate. At baseline, aweak positive corre- 
lation is observed. After isosorbide dinitrate, no correlation was seen. 
Discuss ion 
The present study showed that in untreated hypertensive 
patients without any other coronary risk factors, the lumen size 
of the major left coronary artery branches was not matched to 
the increased coronary flow and that this mismatch was related 
more to the absence of structural enlargement than to changes 
to vascular tone. This absence of coronary enlargement re- 
sulted in a higher flow velocity in hypertensive patients than in 
control subjects, either at baseline or after dilation by intra- 
coronary isosorbide dinitrate. 
Basal and maximal coronary artery dimensions. In normal 
subjects, angiographic studies have shown that at any point of 
the vascular tree there is a direct relation between coronary 
artery lumen area and heart weight (20-22). The internal 
diameter of normal arteries is correlated to blood flow, and 
changes result mainly from remodeling of the arterial wall 
(23,24). 
In experimental hypertrophy (25) and in hypertrophy due to 
aortic valve disease or hypertension, coronary blood flow is 
increased because myocardial oxygen consumption is elevated 
(26-29). However, coronary artery dimensions measured in 
the basal condition are not proportional to the increase in mass 
(]8,30,3]). 
In our study, coronary diameters in hypertensive patients 
were not different from those of patients in group 1 in the basal 
condition, although there was a trend to larger diameters in 
group 2b and to smaller diameters in group 2a. Indeed, it must 
be pointed out that in group 2b after maximal dilation by 
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Figure 5. Top, Flow velocity and diameter changes in the distal left 
anterior descending coronary artery (LAD2) after intracoronary 
isosorbide dinitrate (ISDN) in control subjects and in both groups of 
hypertensive patients. Bottom, Flow velocity/distal left anterior de- 
scending coronary artery (LAD2) ratio in control subjects and in both 
groups of hypertensive patients at baseline and after intracoronary 
isosorbide dinitrate. Numbers in parentheses = number of segments 
analyzed in each patient group. Other abbreviations a in Figure 2. 
**p < 0.01, ***p < 0.001 versus control subjects. 
isosorbide dinitrate, coronary diameters were strictly compa- 
rable to those of group 1, suggesting that patients with left 
ventricular hypertrophy did not have anatomic enlargement of
their coronary arteries. Although our study did not address 
differences between short- and long-term arterial hypertension 
on coronary artery dimensions, it can be reasonably assumed 
that patients with left vcntricular hypertrophy had a longer 
history of the disease than patients without left ventricular 
hypertrophy. Thus, the maladaptation of the coronary artery 
size to the elevated myocardial oxygen demand and to the 
subsequent elevated coronary blood flow seems to be a com- 
mon finding in hypertension, whatever the duration of the 
disease. 
Because body surface area was similar in all three groups, 
the present results cannot be attributed to a low surface area 
before the beginning of the disease, which could have been 
responsible for the initially lower coronary artery dimensions. 
The present results are strikingly different from the enlarge- 
ment observed in aortic valve disease (30), even if the enlarge- 
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Table 4. Hemodynamic Changes Produced by Intracoronary Isosorbide Dinitrate (mean - SD) 
Baseline 
Hypertensive Patients 
Isosorbide Dinitrate 
Hypertensive Patients 
Control Subjects: p Value Control Subjects: p Value 
Group 1 Group 2a Group 2b (group 2a vs. Group 1 Group 2a Group 2b (group 2a vs. 
(n = 10) (n = 12) (n = 14) group 2b) (n = 10) (n = 12) (n = 14) group 2b) 
HR (beats/rnin) 73 +. 10 74 -+ 11 77 + 9 NS 81 +. 11' 78 _+ 12t 83 +_ 10? NS 
[ NS __ J  I _ _  NS .__ J  
I NS I [ NS. I 
SP (ram Hg) 126 +. 10 173 +_ 10 181 +º 15 NS 107 +. 9* 144 _+ 11' 154 +. 18' NS 
[ p < 0.001 __ J  I _ _  p < 0.001 t 
L _ _  p < 0.001 I [ _ _  p < 0.001 I 
HR x SP 9,290 12,728 13,824 NS 8,701 11,256 12,746 <0.05 
(beats/rain.ram Hg) _+1,677 _-2,051 _+1,571 +.1,5807 _+2,185' _+1,136t 
I p < 0.001 __ l  I _ _p  < 0.01 __ J  
I p < 0.001 I L _ _  p < 0.001 _ _ J  
Distal LAD flow 20.1 31.9 43.8 < 0.05 21.0 32.1 39.6 NS 
(ml/min) +.9.8 _+11.4 _+13.5 _+ 10.9:~ -'11.45 _+12.8§ 
I _ _  p < 0.05 I [ _ _  NS .__ J  
L _ _  p < 0.001 I L _ _  p < 0.01 I 
*p < 0.001, tp < 0.01, +p = NS, §p < 0.05 versus baseline values. HR = heart rate; SP = systolic pressure; other abbreviations a  in Tables 1 and 3. 
ment of coronary arteries was behind the increase in the 
myocardial mass. 
Factors that could have affected the coronary artery size, 
such as age, cigarette smoking and cholesterol levels, were 
similar in the three groups. However, it has been reported that 
coronary dimensions are lower in women (18). In our study, 
there were more women in the two hypertensive groups than in 
the control group. The difference was significant between 
groups 2b and 1. Intragroup and intergroup comparisons of 
segment diameters between male and female hypertensive 
patients and the 10 control subjects (there was only one woman 
in the latter group) (Table 3) did not evidence any significant 
differences between the groups. However, diameters tended to 
be lower in women than in men without reaching the threshold 
of significance, probably because of the small number of 
patients in each group. Analysis of results from the male 
patients did not show any significant difference in diameters 
either at baseline or overall after maximal dilation, although 
group 2b showed a trend toward slightly higher diameters than 
the other two groups (Table 3). Moreover, comparison of the 
33 group 1 segments with the 31 group 2a segments and the 24 
group 2b segments in men showed moderately higher diame- 
ters at baseline in group 2b only (3.30 +_ 0.94, 3.24 _ 0.89 and 
3.54 _+ 0.97 mm, respectively), but after isosorbide dinitrate, 
group i and 2b diameters were similar (4.16 _+ 0.95 and 4.26 _+ 
1.07 mm, respectively), and group 2a diameters were lower 
(3.92 +_ 0.87 mm). Finally, the summed cross-sectional area of 
the circumflex and proximal left anterior descending coronary 
arteries in men showed a trend to higher values at baseline but 
similar values after isosorbide dinitrate in group 2b. Overall, 
areas indexed to myocardial mass were significantly lower in 
group 2b than in group 1, and there was a trend toward lower 
values in group 2a (Fig. 3). Thus, it does not seem that the 
greater proportion of women in group 2b could affect the 
major result of this study; that is, coronary arteries are 
undersized in hypertensive patients. 
The absence of increased coronary artery size observed at 
baseline in hypertensive patients may reflect functional or 
structural abnormalities, or both. Coronary vasomotor tone 
may influence basal dimensions. Thus, greater dilating capacity 
has been demonstrated in long-distance runners, who had 
diameters comparable toinactive subjects in the basal state (6). 
A higher coronary vasomotor tone at baseline in group 2a than 
in group 2b may explain the lower diameters in the former 
group. Several factors can increase basal coronary tone in 
hypertensive patients and reduce basal diameter. Coronary 
arteries are innervated with sympathetic nerve fibers (32), and 
increased sympathetic nerve activity occurs in some patients 
with essential hypertension (33-36). Local synthesis of angio- 
tensin II may affect coronary vascular tone (37,38). Functional 
and morphologic changes of endothelial cells (39) may alter 
endothelial vasodilator function (15,40-42) by reducing re- 
lease of endothelial-derived r laxing and hyperpolarizing fac- 
tors (43). Endothelin production could be augmented (44,45). 
In our study, to evaluate the role of vascular tone on 
coronary artery dimensions, we measured iameters after intra- 
coronary administration f isosorbide dinitrate, an endothelium- 
independent coronary vasodilator, to obtain maximal artery 
dimensions. Results show that coronary artery dimensions 
were not increased inhypertensive patients, suggesting that he 
absence of coronary diameter enlargement was not caused by 
an increased vasomotor tone but by structural inability to grow. 
However, a pressure decrease with isosorbide dinitrate might 
have altered maximal diameters. Nevertheless, uch a result is 
mainly observed when vasomotor tone is maintained; when 
vasomotor tone is abolished by isosorbide dinitrate, an average 
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pressure decrease of 20 to 30 mm Hg in the three groups of 
patients hould minimally alter maximal coronary diameters. 
The elevated activity of the renin-angiotensin system (46), 
decreased production of endothelial-derived relaxing factor 
and prostacyclin (47) and enhanced production of endothelin 
(48), in addition to production of growth factors by the 
endothelium, ay be responsible for intimal and medial thick- 
ening in arterial hypertension (49), which impedes any increase 
in coronary artery cross-sectional rea. Human postmortem 
studies of hypertensive patients documented wall thickening in 
large arteries (50,51). Carotid and femoral arteries evidenced 
diameters similar to those in normotensive subjects, along with 
wall thickening (52). However, although the lumen diameters 
of coronary arteries measured by quantitative angiography in
our hypertensive patients were comparable tothose in control 
subjects, we were not able to assess the wall thickness or to 
determine whether vascular growth or remodeling had devel- 
oped. 
Clinical implications. Experimental hypertension i duces 
acceleration of atherosclerotic changes and increases lipid 
deposition (53). Endothelium is involved in the pathophysiol- 
ogy of atherosclerosis (13), and mechanical shear stress of 
endothelial cells plays an important role in endothelial perme- 
ability (54). Because coexistence ofrisk factors and hemorheo- 
logic factors could contribute to the occurrence of an initial 
endothelial lesion initiating the process of atherosclerosis, the 
elevation of coronary flow velocity and endothelial shear stress 
may alter lipid permeability (9). In our study, flow velocity in 
the distal eft anterior descending coronary artery was elevated 
in the two groups of hypertensive patients, either at baseline or 
after isosorbide dinitrate. This observation is the consequence 
of a higher myocardial oxygen demand, evaluated from the 
rate-pressure product, and of a coronary artery diameter that 
is not increased. 
Thus, it appears that in hypertensive patients, the endothe- 
lium is submitted to additional longitudinal stress, which is 
added to the elevated radial pressure stress. These mechanical 
factors could be causal for the higher incidence of coronary 
atherosclerosis in arterial hypertension. 
Study limitations. Despite the high dose of intracoronary 
isosorbide dinitrate used in our study, it might be possible that 
maximal epicardial coronary artery dilation was not achieved 
in hypertensive patients. Nevertheless, we decided not to use 
higher doses of nitrates because of the risk of a significant 
pressure decrease. 
Although hypertension is a risk factor for atherosclerosis, 
the hypertensive patients in our study had no other isk factors 
or angiographic signs of atherosclerosis elsewhere in the 
coronary vasculature. However, intravascular ultrasound stud- 
ies have shown that despite angiographically normal vessels, 
early coronary atherosclerosis can be present (55), and we 
cannot absolutely exclude angiographically undetectable ath- 
erosclerosis. However, all our patients had angiographically 
smooth coronary arteries, and it is unlikely that early athero- 
sclerosis can completely explain our results. 
The method of quantitation of coronary artery diameters 
assumes that the reference catheter (the segment of the 
guiding catheter near the coronary ostium) and vessel seg- 
ments were located in the same plane parallel to the detector. 
This assumption may not be absolutely true. It was also 
assumed that the cross section of the vessels was circular. 
These points could have influenced the absolute values of 
coronary surface area and blood flow but not the relative 
variations of coronary artery dimensions used in the present 
study. 
Last, the use of a crystal end-mounted catheter with a 
zero-crossing detector Doppler velocimeter might not have 
provided accurate measurements of coronary flow velocity 
(56). However, this limitation has been raised for measure- 
ments of flow velocity in stenosed coronary arteries. In addi- 
tion, it has been demonstrated that velocities recorded simul- 
taneously by the former method and by spectral Doppler guide 
wire technique were not significantly different (57). Thus, the 
major results of our study should be valid. 
Conclusions. In hypertensive patients with angiographi- 
cally normal coronary arteries and without any other risk 
factors, the dimensions of the major branches of the left 
coronary artery are not matched with the increased coronary 
flow, either in the basal condition or after vasodilation by 
intracoronary isosorbide dinitrate. Consequently, coronary 
flow velocity is elevated, which may increase endothelial 
longitudinal shear stress, afactor that might promote ndothe- 
lial lesion(s) and dysfunction, initiating the process of athero- 
sclerosis. The reasons why coronary arteries are not enlarged 
remain to be determined. 
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